{"title":"年龄和血糖控制对老年2型糖尿病患者可能的肌肉减少症相关性的性别特异性影响:一项横断面研究","authors":"Yi-Fang Huang, Shih-Ping Liu, Chih-Hsin Muo, Chen-Yi Lai, Chung-Ta Chang","doi":"10.1007/s40520-025-03159-5","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>This study aimed to investigate sex-specific associations and the synergistic effects of aging and glycemic control on the correlation of possible sarcopenia in older adults with type 2 diabetes mellitus (T2DM).</p><h3>Methods</h3><p>In the cross-sectional study of community-dwelling adults aged ≥ 60 years in New Taipei City, Taiwan, Sarcopenia status was classified using the Asian Working Group for Sarcopenia 2019 criteria into possible sarcopenia, sarcopenia, and severe sarcopenia. Categorical and continuous variables were compared using chi-square/Fisher’s exact tests and ANOVA. Sex-specific associations between glycemic control and sarcopenia were examined using logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).</p><h3>Results</h3><p>5,728 participants (mean age 72.1 ± 6.1 years; 47.9% men) were enrolled. After adjustment, older women with T2DM had a higher odds of possible sarcopenia (OR = 2.07, 95% CI = 1.57–2.72). In women aged ≥ 70 years, both good and poor glycemic control were significantly correlated with possible sarcopenia (OR = 1.87 and 2.10; 95% CI = 1.16–3.04 and 1.43–3.07; p for trend < 0.0001). T2DM patients with hypertension, ischemic heart disease (IHD), or depression showed increased sarcopenia association (OR = 1.71, 1.81, and 2.45, respectively). Poor glycemic control revealed increased odds of sarcopenia in those with hypertension (OR = 1.80) or IHD (OR = 2.42).</p><h3>Conclusions</h3><p>Glycemic control could be crucial in preventing possible sarcopenia, especially among older women with T2DM. Comorbid hypertension, IHD, or depression are significantly associated with sarcopenia in T2DM patients, particularly in the presence of poor glycemic control.</p></div>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"37 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40520-025-03159-5.pdf","citationCount":"0","resultStr":"{\"title\":\"Sex‑specific effects of aging and glycemic control on the association of possible sarcopenia in older adults with type 2 diabetes: a cross-sectional study\",\"authors\":\"Yi-Fang Huang, Shih-Ping Liu, Chih-Hsin Muo, Chen-Yi Lai, Chung-Ta Chang\",\"doi\":\"10.1007/s40520-025-03159-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><p>This study aimed to investigate sex-specific associations and the synergistic effects of aging and glycemic control on the correlation of possible sarcopenia in older adults with type 2 diabetes mellitus (T2DM).</p><h3>Methods</h3><p>In the cross-sectional study of community-dwelling adults aged ≥ 60 years in New Taipei City, Taiwan, Sarcopenia status was classified using the Asian Working Group for Sarcopenia 2019 criteria into possible sarcopenia, sarcopenia, and severe sarcopenia. Categorical and continuous variables were compared using chi-square/Fisher’s exact tests and ANOVA. Sex-specific associations between glycemic control and sarcopenia were examined using logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).</p><h3>Results</h3><p>5,728 participants (mean age 72.1 ± 6.1 years; 47.9% men) were enrolled. After adjustment, older women with T2DM had a higher odds of possible sarcopenia (OR = 2.07, 95% CI = 1.57–2.72). In women aged ≥ 70 years, both good and poor glycemic control were significantly correlated with possible sarcopenia (OR = 1.87 and 2.10; 95% CI = 1.16–3.04 and 1.43–3.07; p for trend < 0.0001). T2DM patients with hypertension, ischemic heart disease (IHD), or depression showed increased sarcopenia association (OR = 1.71, 1.81, and 2.45, respectively). Poor glycemic control revealed increased odds of sarcopenia in those with hypertension (OR = 1.80) or IHD (OR = 2.42).</p><h3>Conclusions</h3><p>Glycemic control could be crucial in preventing possible sarcopenia, especially among older women with T2DM. Comorbid hypertension, IHD, or depression are significantly associated with sarcopenia in T2DM patients, particularly in the presence of poor glycemic control.</p></div>\",\"PeriodicalId\":7720,\"journal\":{\"name\":\"Aging Clinical and Experimental Research\",\"volume\":\"37 1\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s40520-025-03159-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aging Clinical and Experimental Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s40520-025-03159-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Clinical and Experimental Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s40520-025-03159-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的本研究旨在探讨年龄和血糖控制在老年2型糖尿病(T2DM)患者可能发生的肌肉减少症之间的性别特异性关联和协同效应。方法在对台湾新北市≥60岁社区居住成年人的横断面研究中,使用亚洲肌肉减少症工作组2019标准将肌肉减少症状况分为可能的肌肉减少症、肌肉减少症和严重的肌肉减少症。分类变量和连续变量采用卡方/Fisher精确检验和方差分析进行比较。使用逻辑回归来估计优势比(ORs)和95%置信区间(ci),检查血糖控制和肌肉减少症之间的性别特异性关联。结果共入组5728例,平均年龄72.1±6.1岁,男性占47.9%。调整后,老年T2DM女性发生肌肉减少症的几率更高(OR = 2.07, 95% CI = 1.57-2.72)。在年龄≥70岁的女性中,血糖控制良好和不良均与可能的肌肉减少症显著相关(OR = 1.87和2.10;95% CI = 1.16-3.04和1.43-3.07;p为趋势值<; 0.0001)。T2DM合并高血压、缺血性心脏病(IHD)或抑郁症患者肌肉减少症的相关性增加(or分别为1.71、1.81和2.45)。血糖控制不良表明高血压(OR = 1.80)或IHD (OR = 2.42)患者肌肉减少症的发生率增加。结论血糖控制对于预防可能的肌肉减少症至关重要,尤其是在老年女性T2DM患者中。合并高血压、IHD或抑郁症与2型糖尿病患者肌肉减少症显著相关,尤其是在血糖控制不良的情况下。
Sex‑specific effects of aging and glycemic control on the association of possible sarcopenia in older adults with type 2 diabetes: a cross-sectional study
Aim
This study aimed to investigate sex-specific associations and the synergistic effects of aging and glycemic control on the correlation of possible sarcopenia in older adults with type 2 diabetes mellitus (T2DM).
Methods
In the cross-sectional study of community-dwelling adults aged ≥ 60 years in New Taipei City, Taiwan, Sarcopenia status was classified using the Asian Working Group for Sarcopenia 2019 criteria into possible sarcopenia, sarcopenia, and severe sarcopenia. Categorical and continuous variables were compared using chi-square/Fisher’s exact tests and ANOVA. Sex-specific associations between glycemic control and sarcopenia were examined using logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results
5,728 participants (mean age 72.1 ± 6.1 years; 47.9% men) were enrolled. After adjustment, older women with T2DM had a higher odds of possible sarcopenia (OR = 2.07, 95% CI = 1.57–2.72). In women aged ≥ 70 years, both good and poor glycemic control were significantly correlated with possible sarcopenia (OR = 1.87 and 2.10; 95% CI = 1.16–3.04 and 1.43–3.07; p for trend < 0.0001). T2DM patients with hypertension, ischemic heart disease (IHD), or depression showed increased sarcopenia association (OR = 1.71, 1.81, and 2.45, respectively). Poor glycemic control revealed increased odds of sarcopenia in those with hypertension (OR = 1.80) or IHD (OR = 2.42).
Conclusions
Glycemic control could be crucial in preventing possible sarcopenia, especially among older women with T2DM. Comorbid hypertension, IHD, or depression are significantly associated with sarcopenia in T2DM patients, particularly in the presence of poor glycemic control.
期刊介绍:
Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.